These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30900179)

  • 41. Human Induced Pluripotent Cell-Derived Sensory Neurons for Fate Commitment of Bone Marrow-Derived Schwann Cells: Implications for Remyelination Therapy.
    Cai S; Han L; Ao Q; Chan YS; Shum DK
    Stem Cells Transl Med; 2017 Feb; 6(2):369-381. PubMed ID: 28191772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.
    Tang ZH; Chen JR; Zheng J; Shi HS; Ding J; Qian XD; Zhang C; Chen JL; Wang CC; Li L; Chen JZ; Yin SK; Huang TS; Chen P; Guan MX; Wang JF
    Stem Cells Transl Med; 2016 May; 5(5):561-71. PubMed ID: 27013738
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous Cell Type-Specific Disrupted in Schizophrenia 1 Interactomes Reveal Protein Networks Associated With Neurodevelopmental Disorders.
    Wilkinson B; Evgrafov OV; Zheng D; Hartel N; Knowles JA; Graham NA; Ichida JK; Coba MP
    Biol Psychiatry; 2019 Feb; 85(4):305-316. PubMed ID: 29961565
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo modeling of neuronal function, axonal impairment and connectivity in neurodegenerative and neuropsychiatric disorders using induced pluripotent stem cells.
    Korecka JA; Levy S; Isacson O
    Mol Cell Neurosci; 2016 Jun; 73():3-12. PubMed ID: 26691153
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Hypoxia epigenetically bestows astrocytic differentiation potential on human pluripotent cell-derived neural stem/precursor cells].
    Yasui T; Nakashima K
    Nihon Yakurigaku Zasshi; 2019; 153(2):54-60. PubMed ID: 30745514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synaptic dysfunction in neurodegenerative and neurodevelopmental diseases: an overview of induced pluripotent stem-cell-based disease models.
    Taoufik E; Kouroupi G; Zygogianni O; Matsas R
    Open Biol; 2018 Sep; 8(9):. PubMed ID: 30185603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Self-Inactivating KamiCas9 System for the Editing of CNS Disease Genes.
    Merienne N; Vachey G; de Longprez L; Meunier C; Zimmer V; Perriard G; Canales M; Mathias A; Herrgott L; Beltraminelli T; Maulet A; Dequesne T; Pythoud C; Rey M; Pellerin L; Brouillet E; Perrier AL; du Pasquier R; Déglon N
    Cell Rep; 2017 Sep; 20(12):2980-2991. PubMed ID: 28930690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of induced pluripotent stem cell (iPSC) lines carrying a heterozygous (UKWMPi002-A-1) and null mutant knockout (UKWMPi002-A-2) of Cadherin 13 associated with neurodevelopmental disorders using CRISPR/Cas9.
    Vitale MR; Zöller JEM; Jansch C; Janz A; Edenhofer F; Klopocki E; van den Hove D; Vanmierlo T; Rivero O; Nadif Kasri N; Ziegler GC; Lesch KP
    Stem Cell Res; 2021 Mar; 51():102169. PubMed ID: 33486346
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term electrophysiological activity and pharmacological response of a human induced pluripotent stem cell-derived neuron and astrocyte co-culture.
    Odawara A; Saitoh Y; Alhebshi AH; Gotoh M; Suzuki I
    Biochem Biophys Res Commun; 2014 Jan; 443(4):1176-81. PubMed ID: 24406164
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
    Yumlu S; Bashir S; Stumm J; Kühn R
    Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Directed differentiation of basal forebrain cholinergic neurons from human pluripotent stem cells.
    Hu Y; Qu ZY; Cao SY; Li Q; Ma L; Krencik R; Xu M; Liu Y
    J Neurosci Methods; 2016 Jun; 266():42-9. PubMed ID: 27036311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Current status of treating neurodegenerative disease with induced pluripotent stem cells.
    Pen AE; Jensen UB
    Acta Neurol Scand; 2017 Jan; 135(1):57-72. PubMed ID: 26748435
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genome Engineering for Stem Cell Transplantation.
    Argani H
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):31-37. PubMed ID: 30777520
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Naïve Induced Pluripotent Stem Cells Generated From β-Thalassemia Fibroblasts Allow Efficient Gene Correction With CRISPR/Cas9.
    Yang Y; Zhang X; Yi L; Hou Z; Chen J; Kou X; Zhao Y; Wang H; Sun XF; Jiang C; Wang Y; Gao S
    Stem Cells Transl Med; 2016 Jan; 5(1):8-19. PubMed ID: 26676643
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differentiation and transplantation of human induced pluripotent stem cell-derived otic epithelial progenitors in mouse cochlea.
    Chen J; Hong F; Zhang C; Li L; Wang C; Shi H; Fu Y; Wang J
    Stem Cell Res Ther; 2018 Aug; 9(1):230. PubMed ID: 30157937
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficient Genome Editing in Induced Pluripotent Stem Cells with Engineered Nucleases In Vitro.
    Termglinchan V; Seeger T; Chen C; Wu JC; Karakikes I
    Methods Mol Biol; 2017; 1521():55-68. PubMed ID: 27910041
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An optogenetic approach for assessing formation of neuronal connections in a co-culture system.
    Su CT; Yoon SI; Marcy G; Chin EW; Augustine GJ; Goh EL
    J Vis Exp; 2015 Feb; (96):e52408. PubMed ID: 25742527
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Patient-derived iPSC modeling of rare neurodevelopmental disorders: Molecular pathophysiology and prospective therapies.
    Sabitha KR; Shetty AK; Upadhya D
    Neurosci Biobehav Rev; 2021 Feb; 121():201-219. PubMed ID: 33370574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent advances of induced pluripotent stem cells application in neurodegenerative diseases.
    Amin N; Tan X; Ren Q; Zhu N; Botchway BOA; Hu Z; Fang M
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109674. PubMed ID: 31255650
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tracking and transforming neocortical progenitors by CRISPR/Cas9 gene targeting and piggyBac transposase lineage labeling.
    Chen F; Rosiene J; Che A; Becker A; LoTurco J
    Development; 2015 Oct; 142(20):3601-11. PubMed ID: 26400094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.